The impact of the crisis on the Irish biopharma and chemical sectors The BioPharma and Chemical sectors stayed essentially operational with most sites employing remote working for 50% of their workforces. A number of critical construction projects were suspended. Some sites have become involved in supplying sanitisers and critical reagents to the HSE. Shortages in some raw materials is emerging as an issue; freight costs have increased signifcantly. Talent development and availability will also present a challenge to the biopharma sector due to a less mobile workforce in the medium to short term; investment decisions may be postponed or delayed.